- Our Story
- Our Methods
- Quality Improvement
- Health Systems Strengthening
- Social and Behavior Change
- Research and Evaluation
- Global Health Security
- HIV and AIDS
- Human Resources for Health (HRH)
- Maternal, Newborn, and Child Health
- Noncommunicable Diseases
- Reproductive Health and Family Planning
- Vulnerable Children and Families
- Water, Sanitation, and Hygiene
- Our Projects
- Our News
- Join Our Team
Cure Tuberculosis Project
The USAID Cure Tuberculosis Project, implemented by JSI Research & Training Institute, Inc. (JSI) in partnership with URC, is a five-year initiative that assists the Kyrgyz government to diagnose, treat, and cure people with drug-resistant tuberculosis (DR-TB).
Cure Tuberculosis works closely with the National Tuberculosis Program under the Ministry of Health and Social Development and national partners to ensure that TB services are both high-quality and accessible, especially for the hardest to reach citizens.
As stigma and discrimination often prevent people from accessing treatment, the project works to reduce TB stigma and discrimination among health care providers and the general public in an effort to ensure that all people with TB have access to treatment regardless of gender, age, or social standing.
The Kyrgyz Republic is one of 30 countries with the highest burden of multi-drug resistant TB (MDR-TB). There are an estimated 1,400 new cases of DR-TB annually. DR-TB is difficult to treat as diagnosis requires collecting sputum from patients for testing in specialized laboratories. The course of treatment for DR-TB is long and requires many different drugs which cause serious side effects.
To reduce the burden of DR-TB, the project strengthens the Kyrgyz government’s efforts to:
- Design, manage, and monitor a system of high-quality TB services available at local health care facilities;
- Ensure that all patients receive the correct treatment regimen with high-quality drugs;
- Strengthen laboratory and diagnostic services;
- Improve infection control in health facilities and laboratories; and
- Expand detection and contact-tracing capabilities in communities and health facilities.
URC is responsible for implementing the clinical component of the project and has attained the following achievements to date.
Increase DR-TB Case Detection
- Optimized the laboratory network in Chui Oblast and implemented the Quality Management System in first-level laboratories
- Implemented an expanded contact investigation approach in two pilot districts
- Developed training programs to improve the quality and timely delivery of samples to TB laboratories
- Developed unified standard reporting forms for regional TB laboratories for monitoring and analysis (including Xpert testing, HAIN test referral, and test turn-around time)
- Assisted the National TB Program and National Reference Laboratory in repurposing functions for COVID-19 treatment and testing and revised infection control procedures
- Developed and piloted a combined diagnostic algorithm for TB and COVID-19
Cure More Patients with DR-TB
- Strengthened DR-TB Concilia (medical council which makes collective decisions about individual DR-TB cases) in Chui Oblast with rollout to other pilot regions
- Developed an advanced DR-TB training curriculum based on MOH-approved national clinical guidelines on management of DR-TB
Prevent DR-TB Infections
- Conducted infection control baseline assessments in six Oblast TB Centers and 18 primary health care organizations and developed four oblast infection control plans for 2020-2021
- Developed an infection control system strengthening mechanism for TB hospitals
2019 to 2024
US Agency for International Development (USAID)
John Snow, Inc., (JSI) Research and Training Institute
Mandatory Health Insurance Fund (MHIF)
Ministry of Health of the Kyrgyz Republic
National Tuberculosis Control Program (NTP)